Novatim's dual-target CAR-T therapy KQ-2003 has been out-licensed for territories outside Greater China
The Clinical Investigator Meeting for KQ-2003, a dual-target CAR-T cell therapy developed by Novatim, was held in Anji, Zhejiang Province
